|
|
Vaccine Detail
|
SARS-CoV S Baculovirus Vaccine |
| Vaccine Information |
- Vaccine Name: SARS-CoV S Baculovirus Vaccine
- Target Pathogen: SARS-CoV
- Target Disease: Severe Acute Respiratory Syndrome (SARS)
- Type: Recombinant vector vaccine
- Status: Research
- Host Species for Licensed Use: None
- Host Species as Laboratory Animal Model: Mouse, Rat
- Antigen: S protein of SARS-CoV (Zhou et al., 2006)
- Immunization Route: intranasal immunization
- Description: recombinant SARS-CoV spike (S) glycoprotein viral vaccine produced in insect cells that is expressed by baculovirus (Zhou et al., 2006)
|
| Host Response |
|
|
| References |
Zhou et al., 2006: Zhou Z, Post P, Chubet R, Holtz K, McPherson C, Petric M, Cox M. A recombinant baculovirus-expressed S glycoprotein vaccine elicits high titers of SARS-associated coronavirus (SARS-CoV) neutralizing antibodies in mice. Vaccine. 2006; 24(17); 3624-3631. [PubMed: 16497416].
|
|
